Showing results (61-70 of 259) with videos related to
Sort By:
Pageof 26
Plos One|March 26, 2015
Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cellsMei-Chuan Tang, Mei-Yi Wu, Ming-Hung Hwang, et al.Future Oncology (London, England)|February 14, 2022
PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancerRachel Woodford, Deborah Zhou, Sarah J Lord, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1)Vera Hirsh, Jacques Cadranel, Xiuyu Julie Cong, et al.Clinical Lung Cancer|January 8, 2013
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancerWei-Yu Liao, Jin-Hsin Chen, Muzo Wu, et al.Frontiers in Oncology|May 16, 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: An Updated Database of 1023 Cases Brief ReportJames Chih-Hsin Yang, Martin Schuler, Sanjay Popat, et al.Lung Cancer (Amsterdam, Netherlands)|December 24, 2013
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)James Chih-Hsin Yang, Yi-Long Wu, Valorie Chan, et al.JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFRKuei-Pin Chung, Shang-Gin Wu, Jenn-Yu Wu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2016
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian PopulationsYen-Fu Chen, Min-Shu Hsieh, Shang-Gin Wu, et al.Journal of Neuro-Oncology|July 3, 2013
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasPei-Fang Wu, Wen-Chang Huang, James Chih-Hsin Yang, et al.Pageof 26